Palvella Therapeutics, Inc. (PVLA) /
The debt of Palvella Therapeutics, Inc. over the past 10 years
Chart Palvella Therapeutics, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Palvella Therapeutics, Inc. had liquid cash of $57.98M and total debt of $0: net cash of $57.98M. It had more liquid cash than debt at all 10 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $57.98M | $0 | $57.98M |
| 2024ended Dec 31, 2024 | $83.6M | $0 | $83.6M |
| 2023ended Dec 31, 2023 | $7.35M | $0 | $7.35M |
| 2022ended Dec 31, 2022 | $59.17M* | $0 | $59.17M |
| 2021ended Dec 31, 2021 | $117.76M* | $0 | $117.76M |
| 2020ended Dec 31, 2020 | $70.44M | $0 | $70.44M |
| 2019ended Dec 31, 2019 | $104.15M* | $0 | $104.15M |
| 2018ended Dec 31, 2018 | $128.11M* | $0 | $128.11M |
| 2017ended Dec 31, 2017 | $72.63M* | $0 | $72.63M |
| 2016ended Dec 31, 2016 | $29.36M* | $0 | $29.36M |
Fiscal years as Palvella Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Palvella Therapeutics, Inc.
- The revenue of Palvella Therapeutics, Inc.
- The profitability of Palvella Therapeutics, Inc.
- The cash flow of Palvella Therapeutics, Inc.
- All of Palvella Therapeutics, Inc.'s financials, charted
Companies of a similar size
- NEOGNeogen Corporation
- PHINPHINIA INC.
- BBTBeacon Financial Corp
- WLYJOHN WILEY & SONS, INC.
- FCPTFour Corners Property Trust, Inc.
Not investment advice. This page shows what Palvella Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.